Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats

Zhao,Neng‑Jiang; Liao,Ming‑Juan; Wu,Jing‑Jing; Chu,Ke‑Xin

doi:10.3892/mmr.2017.7980

Curcumin suppresses Notch‑1 signaling: Improvements in fatty liver and insulin resistance in rats

Authors:
- Neng‑Jiang Zhao
- Ming‑Juan Liao
- Jing‑Jing Wu
- Ke‑Xin Chu
View Affiliations

Affiliations: Department of Internal Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, P.R. China, Department of Traditional Chinese Medicine, the Ninth People's Hospital, Medical School of Shanghai Jiaotong University, Shanghai 200011, P.R. China, Department of Breast, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200011, P.R. China
Published online on: November 6, 2017 https://doi.org/10.3892/mmr.2017.7980
Pages: 819-826
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcumin is a well‑known phenolic substance and has many pharmacological effects associated with metabolism. However, the exact molecular mechanisms underlying this process have yet to be determined. The Notch pathway is a signal transduction pathway involved in energy metabolism. The present study aimed to investigate the effects of curcumin administration on glucose‑lipid metabolism in rats subjected to a high fat diet, and investigate changes in Notch‑1 signaling. Sprague‑Dawley rats (n=40) were randomly divided into four groups (10 rats/group): Control diet group, high fat diet group, high fat diet plus curcumin low dose group and high fat diet plus curcumin high dose group. Following 8 weeks of treatment with curcumin (100 mg/kg in the low dose group and 200 mg/kg in the high dose group), serum metabolic markers and hepatic gene expression patterns were investigated. No differences in body weight following 8 weeks of curcumin administration (P>0.05) were observed; however, curcumin treatment did reduce visceral fat levels (peri‑epididymal and peri‑renal), and decreased cholesterol, triglyceride and low‑density lipoprotein levels in serum compared with the high fat diet rats that did not receive curcumin (P<0.05, P<0.01). An oral glucose tolerance test and an intraperitoneal insulin tolerance test revealed that insulin resistance was reduced (P<0.05 or P<0.01) and tissue section analysis revealed that hepatosteatosis was attenuated following treatment with curcumin. Furthermore, the protein expression of Notch‑1 and its downstream target Hes‑1 were suppressed. These effects were also in parallel with an upregulation of fatty acid oxidation‑associated gene expression, including peroxisome proliferator‑activated receptor (PPAR)‑α, carnitine palmitoyltransferase 1 and PPAR‑γ (P<0.05). In addition, curcumin administration led to a downregulation in the expression of lipogenic genes, including sterol regulatory element‑binding protein, fatty acid synthase and acetyl‑CoA carboxylase (P<0.05). The expression of inflammation‑associated genes, including nuclear factor‑κB, tumor necrosis factor‑α and prostaglandin‑endoperoxide synthase 2 were also suppressed. The results of the present study suggest that the hepatic Notch‑1 pathway can be suppressed via curcumin treatment, which may ameliorate fatty liver and insulin resistance in rats subjected to a high fat diet.

View Figures

View References

1	Chartoumpekis DV, Palliyaguru DL, Wakabayashi N, Khoo NK, Schoiswohl G, O'Doherty RM and Kensler TW: Notch intracellular domain overexpression in adipocytes confers lipodystrophy in mice. Mol Metab. 4:543–550. 2015. View Article : Google Scholar : PubMed/NCBI
2	Carr RM, Oranu A and Khungar V: Nonalcoholic fatty liver disease: Pathophysiology and Management. Gastroenterol Clin North Am. 45:639–652. 2016. View Article : Google Scholar : PubMed/NCBI
3	Schwanbeck R: The role of epigenetic mechanisms in Notch signaling during development. J Cell Physiol. 230:969–981. 2015. View Article : Google Scholar : PubMed/NCBI
4	Lu J, Xia Y, Chen K, Zheng Y, Wang J, Lu W, Yin Q, Wang F, Zhou Y and Guo C: Oncogenic role of the Notch pathway in primary liver cancer. Oncol Lett. 12:42782016.PubMed/NCBI
5	Gridley T and Kajimura S: Lightening up a notch: Notch regulation of energy metabolism. Nat Med. 20:811–812. 2014. View Article : Google Scholar : PubMed/NCBI
6	Kim GW, Lin JE, Blomain ES and Waldman SA: Antiobesity pharmacotherapy: New drugs and emerging targets. Clin Pharmacol Ther. 95:53–66. 2014. View Article : Google Scholar : PubMed/NCBI
7	Kuo JJ, Chang HH, Tsai TH and Lee TY: Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis. Int J Mol Med. 30:673–679. 2012. View Article : Google Scholar : PubMed/NCBI
8	Sha J, Li J, Wang W, Pan L, Cheng J, Li L, Zhao H and Lin W: Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling. Biomed Pharmacother. 84:177–184. 2016. View Article : Google Scholar : PubMed/NCBI
9	Hackler L Jr, Ózsvári B, Gyuris M, Sipos P, Fábián G, Molnár E, Marton A, Faragó N, Mihály J, Nagy LI, et al: The Curcumin Analog C-150, Influencing NF-κB, UPR and Akt/notch pathways has potent anticancer activity in vitro and in vivo. PLoS One. 11:e01498322016. View Article : Google Scholar : PubMed/NCBI
10	Wang Z, Zhang Y, Banerjee S, Li Y and Sarkar FH: Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 106:2503–2513. 2006. View Article : Google Scholar : PubMed/NCBI
11	Yang Y, Duan W, Liang Z, Yi W, Yan J, Wang N, Li Y, Chen W, Yu S, Jin Z and Yi D: Curcumin attenuates endothelial cell oxidative stress injury through Notch signaling inhibition. Cell Signal. 25:615–629. 2013. View Article : Google Scholar : PubMed/NCBI
12	Leclercq IA, Farrell GC, Sempoux C, dela Peña A and Horsmans Y: Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 41:926–934. 2004. View Article : Google Scholar : PubMed/NCBI
13	Liu ZC, Yang ZX, Zhou JS, Zhang HT, Huang QK, Dang LL, Liu GX and Tao KS: Curcumin regulates hepatoma cell proliferation and apoptosis through the Notch signaling pathway. Int J Clin Exp Med. 7:714–718. 2014.PubMed/NCBI
14	Feng XT, Tang SY, Jiang YX and Zhao W: Anti-diabetic effects of zhuoduqing formula, a chines herbal decoction, on a rat model of type 2 diabetes. Afr J Tradit Complement Altern Med. 14:42–50. 2017. View Article : Google Scholar : PubMed/NCBI
15	Ha SK and Chae C: Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. Exp Anim. 59:595–604. 2010. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ1 and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Lallukka S and Yki-Järvinen H: Non-alcoholic fatty liver disease and risk of type 2 diabetes. Best Pract Res Clin Endocrinol Metab. 30:385–395. 2016. View Article : Google Scholar : PubMed/NCBI
18	Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Enjoji M, et al: SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 21:507–511. 2008.PubMed/NCBI
19	Gross B, Pawlak M, Lefebvre P and Staels B: PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 13:36–49. 2016. View Article : Google Scholar : PubMed/NCBI
20	Brzozowa-Zasada M, Piecuch A, Dittfeld A, Mielańczyk Ł, Michalski M, Wyrobiec G, Harabin-Słowińska M, Kurek J and Wojnicz R: Notch signalling pathway as an oncogenic factor involved in cancer development. Contemp Oncol (Pozn). 20:267–272. 2016.PubMed/NCBI
21	Cai Z, Zhao B, Deng Y, Shangguan S, Zhou F, Zhou W, Li X, Li Y and Chen G: Notch signaling in cerebrovascular diseases (Review). Mol Med Rep. 14:2883–2898. 2016. View Article : Google Scholar : PubMed/NCBI
22	Valenti L, Mendoza RM, Rametta R, Maggioni M, Kitajewski C, Shawber CJ and Pajvani UB: Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease. Diabetes. 62:4052–4062. 2013. View Article : Google Scholar : PubMed/NCBI
23	Lai PY, Tsai CB and Tseng MJ: Active form Notch4 promotes the proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun. 430:1132–1139. 2013. View Article : Google Scholar : PubMed/NCBI
24	Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J and Accili D: Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med. 17:961–967. 2011. View Article : Google Scholar : PubMed/NCBI
25	Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN and Accili D: Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med. 19:1054–1060. 2013. View Article : Google Scholar : PubMed/NCBI
26	Ba K, Yang X, Wu L, Wei X, Fu N, Fu Y, Cai X, Yao Y, Ge Y and Lin Y: Jagged-1-mediated activation of notch signalling induces adipogenesis of adipose-derived stem cells. Cell Prolif. 45:538–544. 2012. View Article : Google Scholar : PubMed/NCBI
27	Lei T, Bi Y, Gao MJ, Gao SM, Zhou LL, Zheng HL and Chen XD: HES1 inhibits adipogenesis of porcine mesenchymal stem cells via transcriptional repression of FAD24. Domest Anim Endocrinol. 45:28–32. 2013. View Article : Google Scholar : PubMed/NCBI
28	Musso G, Cassader M, Cohney S, De Michieli F, Pinach S, Saba F and Gambino R: Fatty liver and chronic kidney disease: Novel mechanistic insights and therapeutic opportunities. Diabetes Care. 39:1830–1845. 2016. View Article : Google Scholar : PubMed/NCBI
29	Yao L, Kan EM, Kaur C, Dheen ST, Hao A, Lu J and Ling EA: Notch-1 signaling regulates microglia activation via NF-κB pathway after hypoxic exposure in vivo and in vitro. PLoS One. 8:e784392013. View Article : Google Scholar : PubMed/NCBI
30	Liu Y, Su C, Shan Y, Yang S and Ma G: Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-κB signaling. Am J Transl Res. 8:2681–2692. 2016.PubMed/NCBI